- Home
- MIY vs SRZN Comparison
MIY vs SRZN Comparison
Compare MIY & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIY | SRZN |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.5M | 323.9M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIY | SRZN |
|---|---|---|
| Price | $11.90 | $32.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 70.9K | ★ 125.7K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.57 | $7.11 |
| 52 Week High | $12.90 | $35.00 |
Technical Indicators
Market Signals| Indicator | MIY | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 58.02 |
| Support Level | $11.77 | $23.95 |
| Resistance Level | $12.42 | $33.96 |
| Average True Range (ATR) | 0.22 | 2.57 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 33.99 | 71.96 |
Price Performance
Historical ComparisonAbout MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).